Gilead Sciences (GILD)
$110.46
1.07 (0.96%)
GILD Stock Quote Delayed 30 Minutes
Stock Market Today: Huge Jobs Miss; Amazon Prime Day Delay
Stocks slipped, but didn't plummet in the stock market today despite a horrendous jobs report that highlight the impact of Covid-19.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
138.50B
PE Ratio
1,380.75
EPS
0.08
Volume (Avg. Vol.)
5.91M
Day's Range
$108.40 - $111.07
52-Week Range
$62.07 - $112.11
Dividend & Yield
$3.08 (2.79%)
GILD Stock Predictions, Articles, and Gilead Sciences News
Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap
Gilead Sciences rose to prominence with its hepatitis C drug. Now GILD stock is soaring on hopes for a coronavirus treatment.
Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?
Healthcare stocks lead the way higher on Monday, as equities added another gain to the recent run. Here's the stock market today.
This PR Nightmare for GILD Stock Will Eventually Fade
Once touted as a direct coronavirus play, GILD stock is now receiving heat due to a PR nightmare. But this unfortunate development ultimately won’t affect the bigger picture.
Gilead Stock Flies High With a Potential Coronavirus Treatment
GILD stock could skyrocket if it is first in the door to provide an effective treatment for the coronavirus with its remdesivir drug.
Stock Market Today: Time for Some Good News; Automotive Drama
Stocks hit new 52-week lows in the stock market today, as equities continue to free-fall on coronavirus-related worries.
Gilead Sciences Stock: Still Cheap but Don’t Count On a Coronavirus Rally
Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.
GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes
GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher.
GILD Stock Looks Poised for a Serious Coronavirus Bump
There's a good chance that Gilead's drug will become the coronavirus vaccine, making Gilead stock attractive.
Stock Market Today: Jobs Beat Doesn’t Matter; VIX to Decade High
The VIX topped $50 and hit its highest level in a decade. Here's what else happened in the stock market today.
4 Top Stock Trades for Monday: AMD, WMT, CRM, GILD
Advanced Micro Devices, Walmart, Gilead Sciences and Salesforce were our top stock trades for Monday. That said, here's a look at the charts.
Is Inovio Stock a Buy on Coronavirus Cure Potential?
INO stock has screamed higher on the possibility of a coronavirus vaccine but the underlying company isn't the most fiscally stable.
Forty Seven M&A News: FTSV Stock Soars 62% on $4.9B Gilead Deal
Forty Seven (FTSV) M&A news is seeing FTSV stock soar higher on Monday following news of a $4.9 billion deal with Gilead (GILD).
Stock Market Today: Nowhere to Hide; Cruise Stock Bottom?
There's nowhere to hide, as the markets continue to tumble lower. Here's what happened in the stock market today.
